68% of subjects were on 2 or more medications and all had a baseline medicated IOP ≥ 21 mmHg. Mean medicated IOP at baseline was 24.3 mmHg. There were no cases of suprachoroidal hemorrhage, bleb-related complications, retinal complications or hypotony maculopathy. At 12 months after surgery, mean IOP was 15.2 mmHg with a 41% reduction in IOP from baseline. 86% of patients had a >20% reduction in IOP with a concomitant reduction or no change in IOP-lowering medications.